NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.

导出 LinkOut

翻译打印收藏纠错

第一作者： Constant,Gillot

第一单位： Department of Pharmacy, University of Namur, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, Namur, Belgium.

作者： Constant,Gillot ^[1] ; Julien,Favresse ^[1] ; François,Mullier ^[2] ; Thomas,Lecompte ^[3] ; Jean-Michel,Dogné ^[4] ; Jonathan,Douxfils ^[1]

作者单位： Department of Pharmacy, University of Namur, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, Namur, Belgium. ^[1] Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium. ^[2] Laboratory Hematology, Université Catholique de Louvain, CHU UCL Namur, Namur Research Institute for Life Sciences (NARILIS), Namur Thrombosis and Haemostasis Centre (NTHC), Yvoir, Belgium. ^[3] Division of Angiology and Haemostasis, University Hospitals of Geneva, Geneva, Switzerland. ^[4] Qualiblood s.a., Namur, Belgium. ^[5]

关键词 COVID-19 NETosis SARS-CoV-2 inflammation therapeutics

DOI 10.3389/fphar.2021.708302

PMID 34421600

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2021年12卷

708302页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除